Top COVID-19 Stocks Investors Should Consider

April 4, 2022, By fierce,

The coronavirus isn’t gone just yet.

China just imposed new lockdowns in Shanghai, as the city records some of its highest numbers of new COVID-19 cases.  Italy just reported another 30,710 cases on Monday, and about 59,555 on Sunday. France health authorities just said the number of hospitalized COVID-19 patients jumped to 21,073 since early February.

In the U.S., experts are warning the U.S. could see another spike in cases, with some wastewater samples showing an increase in infections. According to the U.S. CDC, as noted by People, “The U.S. is also starting to see an increase of COVID-19 in wastewater samples, a strong early predictor of when the virus is about to spike. Between Feb. 24 and March 10, the presence of COVID-19 increased by 100% or more in 37% of U.S. wastewater sites, according to the Centers for Disease Control’s tracking system.”

That being said, there’s still a strong need for treatments from companies, such as Revive Therapeutics (OTCQB: RVVTF) (CSE: RVV), Pfizer Inc. (NYSE: PFE), Moderna Inc. (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Merck & Co. Inc. (NYSE: MRK).

Leave a Reply

Your email address will not be published.